Skye Bioscience, Inc. (SKYE) stock
SKYENasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00−0.06 (-6.10%)
Close on Nov 17, 2026Market cap $35.42MP/E –Yield –
Skye Bioscience market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Skye Bioscience's market cap was $32.30M on Nov 11, 2026, against $324.77M a year earlier. Over the last 5 years it ranged from $32.30M to $2.61B, with a median of $198.06M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $32.30M | -82.6% |
| 2025 | Dec 31, 2025 | $185.86M | -72.9% |
| 2024 | Dec 31, 2024 | $686.86M | +155.8% |
| 2023 | Dec 29, 2023 | $268.49M | +323.0% |
| 2022 | Dec 30, 2022 | $63.48M | -68.0% |
| 2021 | Dec 31, 2021 | $198.06M | +147.5% |
| 2020 | Dec 31, 2020 | $80.02M | -43.1% |
| 2019 | Dec 31, 2019 | $140.53M | -67.1% |
| 2018 | Dec 31, 2018 | $427.02M | +1045.0% |
| 2017 | Dec 29, 2017 | $37.30M | -22.5% |
| 2016 | Dec 30, 2016 | $48.11M | -52.5% |
| 2015 | Dec 31, 2015 | $101.24M | – |
See a number that looks wrong?